How GNC Is Making Moves in the Age of Ozempic and Wegovy
GNC CEO, Michael Costello, joins Cheddar to discuss how the wellness business is evolving and what offerings they have similar to GLP-1 drugs. Watch!
More Videos
The Return of Supersonic: Boom’s Test Flight and the Future of Faster Travel
Blake Scholl, Founder & CEO of Boom Supersonic, shares how he launched the company to building the future of flight with test flights and major airline deals.
Earnings Season Heats Up: Analyzing Bank Performance and Market Implications
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Tesla’s Wild Ride: Elon Musk, Robo-Taxis, and the Road Ahead
Jack Ewing of The New York Times unpacks Tesla’s delivery slump, Musk’s political clash with Trump, robo-taxis, and the current state of Dogecoin.
Are Millennials and Gen Z Moving On from Spirits? Bacardi’s Tony Latham Weighs In
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Who Will Rule the Summer Box Office? Superman or Jurassic World Rebirth
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU Breaks Ground on 20,000‑Seat ‘Sunset Amphitheater’ Featuring Luxe Suites & Aikman Club
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
